COVID-19 lockdown in India : ShopClues to deliver essential items in 48 hours in Delhi and Gurugram

COVID-19 lockdown in India : ShopClues to deliver essential items in 48 hours in Delhi and Gurugram

COVID-19 lockdown in India : ShopClues, an Indian online marketplace, announced that orders of essential items would be delivered for its Delhi and Gurugram customers within 48 hours. The service began early April following a lockdown announced by the Indian government to handle the coronavirus crisis in the country. ShopClues started the service to enable […]

Incyte to launch ruxolitinib coronavirus clinical trial in US

Incyte to launch ruxolitinib coronavirus clinical trial in US

Ruxolitinib coronavirus clinical trial : Incyte revealed that it is working with the US Food and Drug Administration (FDA) to launch the phase 3 RUXCOVID clinical trial to assess the efficacy and safety of ruxolitinib (Jakafi) plus standard-of-care (SoC) in patients with COVID-19 associated cytokine storm syndrome. The ruxolitinib plus standard-of-care will be compared to […]

Promega master mix approved for use in CDC’s COVID-19 diagnostic panel

Promega master mix approved for use in CDC’s COVID-19 diagnostic panel

Promega Corporation said that its GoTaq Probe 1-Step RT-qPCR System is now available in Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. Available through the CDC’s Emergency Use Authorization (EUA), the Promega tool is an approved master mix option for the 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel of the CDC. Recently, […]

BharatPe, ICICI Lombard launch coronavirus insurance product for shopkeepers

BharatPe, ICICI Lombard launch coronavirus insurance product for shopkeepers

Indian payments company BharatPe has partnered with ICICI Lombard to provide a coronavirus insurance product called the ‘COVID-19 Protection Insurance Cover’ for shopkeepers across the country. The new COVID-19 insurance product from BharatPe and the ICICI Bank subsidiary is claimed to enable policyholders to get 100% of their hospitalization expenses arising from the novel coronavirus […]

Lab established in Liverpool to study how novel coronavirus affects people

Lab established in Liverpool to study how novel coronavirus affects people

The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool, the Imperial College London, and the University of Edinburgh to handle the coronavirus outbreak from the government’s rapid response call. This investment in Urgent Public Health Research is necessary to understand COVID-19 as well as its impact on the human […]

Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins

Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins

Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from the US Food and Drug Administration (FDA). The company has launched the coronavirus detection test following the FDA approval. According to Abbott, the ID NOW platform is the fastest available […]

behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal

behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal

behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects the ‘instant triage’ to enable an expedited diagnosis of novel coronavirus cases and ensure resources are properly allocated. According to behold.ai, its red dot algorithm was trained […]

BioDuro launches AI-driven COVID-19 nanobody therapeutic program

BioDuro launches AI-driven COVID-19 nanobody therapeutic program

BioDuro said that it has launched a COVID-19 nanobody therapeutic program by leveraging its biologics discovery platform, which makes use of artificial intelligence computing and high-speed DNA mutagenesis technology. The life sciences contract research and development organization expects to screen over 10 billion human synthetic antibodies generated by its technology platform. BioDuro said that its […]